SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 26th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledSeptember 26th, 2012 Company Industry JurisdictionThis SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (as same may be further amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), dated as of March 17, 2010 and amended and restated as of September 21, 2012, is entered into by and among Unigene Laboratories, Inc., a Delaware corporation (the “Company”), and the lender(s) listed on the Schedule of Buyers attached hereto (each, a “Buyer” and, collectively, the “Buyers”).
FORBEARANCE AGREEMENT AND FIRST AMENDMENT TO AMENDED AND RESTATED FINANCING AGREEMENTForbearance Agreement and First Amendment to Amended and Restated Financing Agreement • September 26th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledSeptember 26th, 2012 Company Industry JurisdictionThis FORBEARANCE AGREEMENT AND FIRST AMENDMENT TO AMENDED AND RESTATED FINANCING AGREEMENT (this “Amendment”) is made and entered into as of September 21, 2012 by and among Unigene Laboratories, Inc., a Delaware corporation (“Principal Borrower”), the financial institutions party hereto as “Lenders” (collectively, “Lenders”), and Victory Park Management, LLC, as administrative agent and collateral agent (in such capacity, “Agent”) for Lenders and the Holders (as defined in the Financing Agreement (as defined below)); all capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to them in the Financing Agreement or, if not defined in the Financing Agreement, the respective meanings ascribed to them in the Notes.
INDEMNIFICATION AGREEMENTIndemnification Agreement • September 26th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Delaware
Contract Type FiledSeptember 26th, 2012 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (this “Agreement”) is entered into as of September 21, 2012, by and between Unigene Laboratories, Inc., a Delaware corporation (the “Company”), and Richard N. Levy (“Indemnitee”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • September 26th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Delaware
Contract Type FiledSeptember 26th, 2012 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (this “Agreement”) is entered into as of September 21, 2012, by and between Unigene Laboratories, Inc., a Delaware corporation (the “Company”), and [_______________], a Unigene Laboratories, Inc. Board Director (“Indemnitee”).
PATENT SECURITY AGREEMENTPatent Security Agreement • September 26th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledSeptember 26th, 2012 Company Industry JurisdictionThis PATENT SECURITY AGREEMENT (this “Agreement”), dated as of September 21, 2012, by Unigene Laboratories, Inc., a Delaware corporation (the “Grantor”), in favor of Victory Park Management, LLC, as collateral agent (the “Collateral Agent”) for the secured parties referred to below.
TRADEMARK SECURITY AGREEMENTTrademark Security Agreement • September 26th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledSeptember 26th, 2012 Company Industry JurisdictionThis TRADEMARK SECURITY AGREEMENT (this “Agreement”), dated as of September 21, 2012, by Unigene Laboratories, Inc., a Delaware corporation (the “Grantor”), in favor of Victory Park Management, LLC, as collateral agent (the “Collateral Agent”) for the secured parties referred to below.
SECOND AMENDMENT TO RIGHTS AGREEMENTRights Agreement • September 26th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledSeptember 26th, 2012 Company Industry JurisdictionThis SECOND AMENDMENT TO RIGHTS AGREEMENT, dated as of September 21, 2012 (this “Second Amendment”), is entered into by and between UNIGENE LABORATORIES, INC., a Delaware corporation (the “Company”), and REGISTRAR AND TRANSFER COMPANY, a New Jersey corporation (the “Rights Agent”). Capitalized terms used but otherwise not defined herein shall have the respective meanings ascribed to such terms in the Rights Agreement (as hereinafter defined).